Clinical Trial Update: Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma [Phase 2, Phase 3]

View source ↗

Summary

This document reports a Phase 2/3 clinical trial evaluating the efficacy and safety of Budesonide Novolizer Dry Powder Inhaler 200 μg in Chinese patients with m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide Novolizer Dry Powder Inhaler 200 μg (budesonide)

Snippet

Sponsor: NovaMed Pharmaceuticals Inc. | Conditions: Asthma | Phase 2, Phase 3 | Status: UNKNOWN